Optimal asthma control, starting with high doses of inhaled budesonide

European Respiratory Journal

Volumn 16, Issue 2, 2000, Pages 226-235

  Reddel, H K ^a   Jenkins, C R ^a   Marks, G B ^a   Ware, S I ^a   Xuan, W ^a   Salome, C M ^a   Badcock, C A ^b   Woolcock, A J ^a  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^b ASTRAZENECA   (United Kingdom)

Author keywords

Asthma; Asthma prevention and control; Bronchial hyperreactivity; Budesonide; Drug administration schedule; Randomized controlled trials

Indexed keywords

BUDESONIDE; HISTAMINE;

ARTICLE; ASTHMA; BRONCHUS HYPERREACTIVITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; MAJOR CLINICAL STUDY; MALE; PEAK EXPIRATORY FLOW; PRIORITY JOURNAL; PROVOCATION TEST; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADMINISTRATION, INHALATION; ADULT; AGED; ASTHMA; BRONCHIAL HYPERREACTIVITY; BRONCHODILATOR AGENTS; BUDESONIDE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; FORCED EXPIRATORY VOLUME; HISTAMINE; HUMANS; MALE; MIDDLE AGED; PEAK EXPIRATORY FLOW RATE; SINGLE-BLIND METHOD; TREATMENT OUTCOME;

EID: 0033893557     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-3003.2000.16b08.x     Document Type: Article

References (39)

1. The assessment and treatment of asthma a conference report
2. High dose fluticasone propionate, 1 mg daily, versus fluticasone propionate, 2 mg daily, or budesonide, 1.6 mg daily, in patients with chronic severe asthma
3. Effects of the long-acting beta-agonist formoterol on asthma control in asthmatic patients using inhaled corticosteroids
4. Budesonide delivered by Turbuhaler(TM) is effective in a dose-dependent fashion when used in the treatment of adult patients with chronic asthma
5. Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment
6. Current issues for establishing inhaled corti-costeroids as the antiinflammatory agents of choice in asthma
7. The British Guidelines on Asthma Management. 1995 Review and Position statement
8. Starting with a higher dose of inhaled corticosteroids in primary care asthma treatment
9. Effects of inhaled fluticasone and oral prednisolone on clinical and inflammatory parameters in patients with asthma
10. International Consensus Report on Diagnosis and Treatment of Asthma
11. New regression equations for predicting peak expiratory flow in adults
12. A scoring system for mild to severe asthma
13. Fifteen-year interval spirometric evaluation of the Oregon predictive equations
14. Rapid method for measurement of bronchial responsiveness
15. Expression of results of airway hyperresponsiveness
16. Pitfalls in processing electronic spirometric data in asthma
17. Standardization of spirometry, 1994 update
18. A scale for the measurement of quality of life in adults with asthma
19. Which index of peak expiratory flow is most useful in the management of stable asthma?
20. New regression equations for predicting peak expiratory flow in adults
21. Effect of long-term treatment with an inhaled corticosteroid (budesonide) on airway hyperresponsiveness and clinical asthma in non-steroid-dependent asthmatics
22. Relationship between the inflammatory infiltrate in bronchial biopsy specimens and clinical severity of asthma in patients treated with inhaled steroids
23. Rate of decline of lung function in subjects with asthma
24. Dosage and time effects of inhaled budesonide on bronchial hyper-reactivity
25. Effect of differing doses of inhaled budesonide on markers of airway inflammation in patients with mild asthma
26. Effects of budesonide by means of the Turbuhaler(TM) on the hypothalmic-pituitary-adrenal axis in asthmatic subjects: A dose-response study
27. Effect of therapy on bronchial hyperresponsiveness in the long-term management of asthma
28. Long-term effects of budesonide on airway responsiveness and clinical asthma severity in inhaled steroid-dependent asthmatics
29. Time course of change in bronchial reactivity with an inhaled corticosteroid in asthma
30. High-dose inhaled steroids in the management of asthma. A comparison of the effects of budesonide and beclomethasone dipropionate on pulmonary function, symptoms, bronchial responsiveness and the adrenal function
31. Effect of early vs late intervention with inhaled corticosteroids in asthma
32. Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma
33. Effects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children
34. Compliance with peak expiratory flow monitoring in home management of asthma
35. Reduction of budesonide after a year of increased use: A randomized controlled trial to evaluate whether improvements in airway responsiveness and clinical asthma are maintained
36. 2-agonist, terbutaline, on airway inflammarion m newly diagnosed asthma: A randomized, double-blind, parallel-group controlled trial